- Report
- March 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- March 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- February 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- February 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- January 2025
- 175 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- January 2025
- 175 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- July 2025
Global
From €4333EUR$4,900USD£3,755GBP
- Report
- April 2025
Global
From €4333EUR$4,900USD£3,755GBP
- Report
- August 2025
- 368 Pages
Global
From €5173EUR$5,850USD£4,482GBP
- Report
- August 2025
- 383 Pages
Global
From €5173EUR$5,850USD£4,482GBP
- Report
- August 2025
- 297 Pages
Global
From €5173EUR$5,850USD£4,482GBP
- Report
- August 2025
- 171 Pages
Global
From €5173EUR$5,850USD£4,482GBP
- Report
- August 2025
- 250 Pages
Global
From €5173EUR$5,850USD£4,482GBP
- Report
- August 2025
- 280 Pages
Global
From €5173EUR$5,850USD£4,482GBP
- Clinical Trials
- July 2025
- 280 Pages
Global
From €2653EUR$3,000USD£2,299GBP
- Report
- April 2025
- 200 Pages
Global
From €7030EUR$7,950USD£6,091GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1769EUR$2,000USD£1,532GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1326EUR$1,500USD£1,149GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1105EUR$1,250USD£958GBP
- Drug Pipelines
- September 2024
- 247 Pages
Global
From €7030EUR$7,950USD£6,091GBP

Somatostatin is a peptide hormone that is used in the treatment of various types of cancer. It is used to inhibit the release of growth hormones, which can help reduce the size of tumors. It is also used to reduce the side effects of chemotherapy and radiation therapy. Somatostatin is available in both injectable and oral forms. It is often used in combination with other drugs to treat cancer.
Somatostatin is used to treat a variety of cancers, including pancreatic, prostate, and neuroendocrine tumors. It is also used to treat acromegaly, a condition caused by excessive growth hormone production. Somatostatin is also used to treat Cushing's syndrome, a condition caused by excessive cortisol production.
Some companies that produce somatostatin include Novartis, Merck, and Pfizer. Other companies that produce somatostatin-based drugs include Ipsen, Teva, and Sandoz. Show Less Read more